Courtney Dugan | executive |
Thomas Gad | executive |
Michael Rossi | executive |
Sue Smith | executive |
Steen Lisby | executive |
Bo Kruse | executive |
Alec Stranahan | analyst |
Charles Zhou | analyst |
William Morgan | analyst |
Etzer Darout | analyst |
Michael Ulz | analyst |
Robert Burns | analyst |
Good morning, and welcome to Y-mAbs Therapeutics Third Quarter 2023 Earnings Conference Call. Please note that today's event is being recorded. At this time, all participants are in a listen-only mode. Instructions for the question-and-answer session will follow the prepared remarks. I would now like to turn the conference call over to Courtney Dugan, Vice President, Investor Relations.